Antisynthetase syndrome – Life with Disease

Go back

Antisynthetase syndrome is a rare autoimmune condition that causes the body’s immune system to mistakenly attack healthy tissues, leading to inflammation in muscles, lungs, joints, skin, and blood vessels. Living with this complex condition means facing uncertainty about disease progression, managing multiple symptoms that can affect daily activities, and navigating treatment options while watching for possible complications. Understanding what to expect as the disease unfolds and how it may shape life ahead can help patients and their families prepare, adapt, and make informed decisions about care.

Prognosis and Survival Outlook

Understanding what the future may hold when diagnosed with antisynthetase syndrome can be challenging, especially because this condition affects each person differently. The outlook depends largely on which parts of the body are affected and how severely, particularly the lungs. While there is currently no cure for antisynthetase syndrome, many people can manage their symptoms and maintain a reasonable quality of life with appropriate treatment[1].

Research suggests that the estimated ten-year survival rate for patients with antisynthetase syndrome is approximately 76.8%[2]. This means that roughly three out of four people diagnosed with the condition are alive ten years later. It’s believed that the mortality rate for antisynthetase syndrome is significantly higher than that of the general population[2], reflecting the serious nature of this disease.

The presence and severity of interstitial lung disease (a condition where the tissue between the air sacs in the lungs becomes damaged and stiff) is the most important factor affecting long-term survival. Studies show that mortality risk is not necessarily increased simply because someone has antisynthetase syndrome, but severe and extensive interstitial lung disease is most frequently associated with early death[4][9]. Between 67% and 100% of people with antisynthetase syndrome develop some degree of lung involvement[2], and for some individuals, lung disease may be the first or only symptom they experience[4].

The lung disease associated with antisynthetase syndrome can be severe and rapidly progressive, causing much of the increased illness and mortality compared to other similar muscle diseases[3][8]. Some people may eventually develop pulmonary hypertension (increased pressure in the blood vessels of the lungs), which can occur with or without existing interstitial lung disease[3][7]. In the most severe cases, progressive lung disease may advance to the point where lung transplantation becomes necessary[3][8].

⚠️ Important
Early and accurate diagnosis is vital for proper treatment, especially when there is lung involvement. Seeing a doctor with experience in antisynthetase syndrome is highly recommended to ensure the best possible outcomes and to minimize the risk of serious complications.

On a more positive note, antisynthetase syndrome can go into remission in some cases, especially for those with milder lung disease[4][9]. Patients are more likely to remain symptom-free when they continue treatment rather than stopping medications abruptly. Disease flares (periods when symptoms worsen) tend to occur when medications are reduced or tapered too rapidly[4][9].

Natural Progression of the Disease

Without treatment, antisynthetase syndrome typically follows a pattern of worsening inflammation affecting multiple body systems. The disease doesn’t develop in exactly the same way for everyone, but certain patterns are commonly observed. The symptoms often appear gradually, though in some cases they can come on suddenly.

Muscle inflammation, known as myositis, is one of the hallmark features. About 91% of patients with antisynthetase syndrome experience muscle weakness[2]. The severity can range from barely noticeable (subclinical) to substantial weakness in the muscles closest to the body’s center, making it difficult to climb stairs, reach overhead cupboards, or get up from a seated position[2]. Between 30% and 89% of people report persistent muscle tenderness and pain[2]. If left untreated, this muscle weakness can progress and may eventually affect the throat muscles that help with swallowing, a condition called dysphagia, which increases the risk of choking or breathing food or liquid into the lungs[1].

Lung disease develops in 67% to 100% of people with antisynthetase syndrome[2][4]. Breathing difficulties (dyspnea) and a dry cough are the most common lung symptoms[2]. These respiratory symptoms may appear early on, alongside other symptoms, or they may show up later in the disease’s progression[2]. Recent research has shown that fluid buildup around the lungs (pleural effusions) is often associated with antisynthetase syndrome, occurring in about 42% of patients[2]. Without treatment, the lung tissue becomes increasingly scarred and stiff, making breathing progressively harder and reducing the body’s ability to get enough oxygen.

Joint involvement is another common feature. Between 18% and 55% of people with inflammatory muscle diseases like antisynthetase syndrome experience arthritis[2]. In antisynthetase syndrome, this typically presents as a symmetrical, non-erosive polyarthritis (inflammation affecting five or more joints at once), most often involving the small joints of the hands and feet[2]. While this arthritis doesn’t usually cause the kind of joint deformity seen in rheumatoid arthritis[4], about 50% of patients develop changes visible on X-rays, such as erosions, calcium deposits around joints, or partial dislocations[2]. Arthritis is the first symptom for about 24% to 66% of patients, which can often lead to delays in getting the correct diagnosis[2].

Skin changes are also part of the disease’s natural progression. About 30% of patients develop a condition called mechanic’s hands, where the skin on the palms and sides of the fingers becomes thickened, dry, and cracked, resembling the rough, calloused hands of someone who does manual labor[1][4][7]. This can be painful and limit hand function.

About 40% of people with antisynthetase syndrome experience Raynaud’s phenomenon, episodes where blood flow to the fingers and toes is temporarily reduced, usually triggered by cold temperatures or stress[7]. During these episodes, the affected areas may feel numb and cold and turn white, then blue, and finally red as blood flow returns. Episodes can last several minutes to several hours[4].

Fevers that aren’t related to infection occur in about 20% to 30% of patients[4][7][9]. These unexplained fevers may appear at the onset of the disease and may persist or come back during disease flares.

Possible Complications

Antisynthetase syndrome can lead to several serious complications, some directly related to the disease itself and others stemming from the inflammation and damage it causes to various organs. Understanding these potential complications helps patients and families recognize warning signs early.

The most significant complication is progressive interstitial lung disease. As the tissue between the air sacs in the lungs becomes increasingly damaged and scarred, breathing becomes more difficult. This can lead to chronic shortness of breath, persistent cough, fatigue, and chest discomfort[1][6]. The lung disease in antisynthetase syndrome patients is often severe and rapidly progressive[3][8], and in extreme cases may progress to the point where a lung transplant is the only remaining treatment option[3][8].

Pulmonary hypertension, a condition where the blood pressure in the arteries of the lungs becomes abnormally high, can develop in patients with antisynthetase syndrome. This can occur whether or not someone already has interstitial lung disease[3][7]. Pulmonary hypertension puts extra strain on the heart and can cause symptoms like extreme fatigue, dizziness, chest pain, and worsening shortness of breath.

Weakness of the throat muscles can lead to dysphagia, or difficulty swallowing. This complication is particularly concerning because it can result in aspiration pneumonia, a type of lung infection that occurs when food, liquid, or saliva is breathed into the lungs instead of being swallowed into the stomach[7]. Aspiration pneumonia can be serious and requires prompt medical attention.

When the muscles involved in breathing become weak, this can lead to shortness of breath even beyond what’s caused by lung disease itself[7]. This respiratory muscle weakness can make it harder to cough effectively, increasing the risk of lung infections.

Some case studies have reported various cancers (malignancies) occurring within six to twelve months of the diagnosis of antisynthetase syndrome[7]. While patients with antisynthetase syndrome are actually less likely to experience cancer-associated muscle disease than those with some other inflammatory muscle conditions[4][9], doctors still recommend age-appropriate cancer screening as a precaution, similar to the screening recommended for people with dermatomyositis[7].

Long-term treatment with immunosuppressive medications, while necessary to control the disease, brings its own set of complications. Patients receiving these treatments face an increased risk of infections, possible side effects from the medications themselves, and potential complications related to chronic use of steroids such as weight gain, bone thinning (osteoporosis), high blood sugar, and mood changes[3][8].

⚠️ Important
The long-term care of patients with antisynthetase syndrome requires careful attention to both the adverse effects and complications of chronic immunosuppressive therapy, as well as disease-related problems that can include progressive lung disease, pulmonary hypertension, potential malignancy, and decreased survival. Regular monitoring by healthcare providers is essential.

Impact on Daily Life

Living with antisynthetase syndrome can significantly affect nearly every aspect of daily life, from physical abilities to emotional well-being, social relationships, work capacity, and leisure activities. The extent of impact varies greatly depending on which symptoms are present and how severe they are.

Physical limitations are often the most obvious challenges. Muscle weakness, particularly in the muscles closest to the body’s trunk, can make everyday tasks surprisingly difficult. Simple activities like getting dressed, brushing hair, reaching items on high shelves, climbing stairs, or rising from a chair can become exhausting or impossible without assistance[2]. Walking even short distances may leave someone breathless if lung disease is present, forcing them to plan activities around rest periods and limiting spontaneous outings.

Extreme fatigue is a common complaint and can be life-altering[1][6]. This isn’t ordinary tiredness that improves with rest; it’s a profound exhaustion that can persist even after a full night’s sleep. Many people find they have only enough energy for essential tasks and must carefully budget their limited stamina throughout the day.

Joint pain and stiffness can interfere with fine motor tasks such as writing, typing, buttoning clothes, or preparing meals. When combined with mechanic’s hands—the painful, cracked skin on the palms and fingers—even simple activities like washing dishes or opening containers can become uncomfortable[4].

Raynaud’s phenomenon can make cold weather particularly challenging. Individuals may need to dress more warmly than others, wear gloves even for minor cold exposure (like reaching into a freezer), and plan their activities around temperature considerations[4].

The emotional and psychological impact of antisynthetase syndrome should not be underestimated. Living with a chronic, incurable condition that affects multiple body systems can lead to anxiety, depression, frustration, and grief over lost abilities. The unpredictability of flares—periods when symptoms worsen—adds to the stress, as people never quite know when they’ll feel worse. Many patients struggle with feelings of isolation, especially since antisynthetase syndrome is rare and not well understood by the general public.

Social relationships may be strained as patients find themselves unable to participate in activities they once enjoyed with friends and family. Canceled plans due to fatigue or symptom flares can lead to misunderstandings if loved ones don’t fully grasp the unpredictable nature of the disease. Some people with antisynthetase syndrome may appear healthy to others, making it difficult for friends and acquaintances to understand why they’re unable to do certain things—this “invisible illness” aspect can be particularly frustrating.

Work capacity is often significantly affected. Depending on the severity of symptoms, some people can continue working with accommodations such as modified schedules, frequent breaks, the ability to work from home, or assistive devices. Others may find they need to reduce their hours, change to less physically demanding roles, or stop working altogether. The financial implications of reduced work capacity, combined with medical expenses, can add considerable stress to an already challenging situation.

Hobbies and leisure activities may need to be adapted or abandoned. Physical activities like sports, gardening, or dancing might become impossible due to muscle weakness and fatigue. Even less active hobbies may be affected—someone with breathing difficulties might struggle with activities like singing, while joint pain and mechanic’s hands could interfere with crafts or playing musical instruments.

Maintaining an active and healthy lifestyle is very important for people with antisynthetase syndrome. Physical and occupational therapy can be very helpful in strengthening muscles and adapting to limitations[15]. Going to these therapy sessions can help patients learn exercises and strategies to maintain as much function as possible. Pulmonary rehabilitation programs can help those with lung involvement learn breathing techniques and exercises to maximize their lung capacity.

A healthy diet and appropriate exercise, within the limits of one’s abilities, remain important. Staying up to date with vaccinations is crucial since immunosuppressive medications increase infection risk[20]. Some patients may benefit from assistive devices such as canes, shower chairs, or grab bars to help with mobility and safety at home.

Support for Family Members

When someone is diagnosed with antisynthetase syndrome, their family members also begin a journey of adaptation, learning, and support. Families play a crucial role not only in day-to-day caregiving but also in helping their loved one navigate the medical system, make treatment decisions, and potentially participate in clinical trials that could advance understanding of this rare disease.

Understanding that antisynthetase syndrome is a rare autoimmune disease helps families grasp why their loved one is experiencing such varied symptoms affecting muscles, lungs, joints, and skin. It’s important for family members to learn that this is not a condition their loved one caused or could have prevented—it results from the immune system mistakenly attacking the body[1]. Recognizing that symptoms can fluctuate, with periods of relative stability punctuated by flares, helps families understand why their loved one’s abilities may vary from day to day or week to week.

Clinical trials are research studies that test new treatments or gather information about diseases. For a rare condition like antisynthetase syndrome, clinical trials are particularly important because they help researchers understand the disease better and develop more effective treatments. Families should know that participating in clinical trials is voluntary and that their loved one can withdraw at any time.

When considering clinical trial participation, families can assist in several practical ways. They can help research available trials by looking at resources online or asking healthcare providers about ongoing studies. Many medical centers that specialize in myositis (inflammatory muscle diseases) conduct research and may have information about relevant clinical trials. Families can help their loved one understand the purpose of a trial, what participation would involve, potential benefits and risks, and time commitments required.

The decision to participate in a clinical trial is deeply personal and should be made jointly by the patient, their family, and their healthcare team. Families can support this decision-making by attending medical appointments where trials are discussed, taking notes, asking questions about anything unclear, and helping their loved one weigh the pros and cons. Questions families might help ask include: What is being tested in this trial? How might it help? What are the possible side effects or risks? How much time will it require? Will there be additional medical visits or tests? Are there any costs?

If a decision is made to participate in a trial, families can provide practical support in numerous ways. They can help with transportation to appointments, accompany their loved one to visits for moral support and to help remember information, keep track of appointments and medication schedules related to the trial, watch for and report any changes in symptoms or side effects, and help maintain communication with the research team.

Beyond clinical trials, families benefit from learning how to provide day-to-day support. This includes understanding their loved one’s limitations without being overprotective, helping them maintain as much independence as possible, recognizing signs that symptoms are worsening and medical attention may be needed, and creating a supportive home environment that accommodates physical limitations (such as ensuring commonly used items are within easy reach).

Family members should also remember to care for themselves. Caregiving can be physically and emotionally exhausting. Seeking their own support through counseling, support groups for caregivers, or simply ensuring they maintain their own health and social connections is not selfish—it’s necessary for them to be able to continue supporting their loved one effectively.

Staying connected with healthcare professionals who have experience with antisynthetase syndrome is valuable for both patients and families. Don’t hesitate to reach out with questions or concerns, and keep open lines of communication with the medical team. Many patients and families find support through organizations dedicated to myositis and rare diseases, where they can connect with others facing similar challenges and access educational resources.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Prednisone (Corticosteroids) – Used to reduce inflammation and control symptoms; typically started at high doses then gradually tapered
  • Azathioprine – An immunosuppressant medication used to manage lung and muscle symptoms alongside corticosteroids
  • Mycophenolate mofetil – An immunosuppressive agent often used in combination therapy to control disease manifestations
  • Tacrolimus – An immunosuppressant medication used to help manage muscle and pulmonary symptoms
  • Cyclophosphamide – An immunosuppressant used in more severe cases to control inflammation
  • Rituximab – A biologic agent recommended for refractory cases when other treatments are insufficient
  • Methylprednisolone (IV) – Pulsed intravenous corticosteroid used in severe cases requiring intensive initial treatment
  • Etanercept (Enbrel) – An anti-TNF inhibitor that may be used when arthritis symptoms are predominant
  • Adalimumab (Humira) – An anti-TNF inhibitor typically used for rheumatoid arthritis, may be considered when arthritis is a major feature
  • Anakinra – An IL-1 receptor antagonist being studied as an alternative treatment for refractory cases

Ongoing Clinical Trials on Antisynthetase syndrome

  • Study on Upadacitinib for Patients with Idiopathic Inflammatory Myopathies After Stopping IVIG

    Recruiting

    2 1 1
    Investigated drugs:
    Austria
  • Study on Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Efficacy and Safety of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑synthetase Inflammatory Myositis

    Not recruiting

    2 1 1
    Investigated drugs:
    Czechia France Germany Italy Spain

References

https://my.clevelandclinic.org/health/diseases/25159-antisynthetase-syndrome

https://en.wikipedia.org/wiki/Antisynthetase_syndrome

https://pmc.ncbi.nlm.nih.gov/articles/PMC5006392/

https://www.myositis.org/about-myositis/complications/antisynthetase-syndrome/

https://www.aiarthritis.org/antisynthetase-syndrome-blog

https://med.uth.edu/neurosciences/antisynthetase-syndrome/

https://dermnetnz.org/topics/antisynthetase-syndrome

https://pmc.ncbi.nlm.nih.gov/articles/PMC5006392/

https://www.myositis.org/about-myositis/complications/antisynthetase-syndrome/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8890853/

https://my.clevelandclinic.org/health/diseases/25159-antisynthetase-syndrome

https://www.jrheum.org/content/50/1/151

https://www.institut-myologie.org/en/2024/12/11/from-diagnosis-to-treatment-antisynthetase-syndrome-is-attracting-international-attention/

https://my.clevelandclinic.org/health/diseases/25159-antisynthetase-syndrome

https://www.hopkinsmyositis.org/educational-resources/antisynthetase-syndrome-lifestyle-options/

https://www.aiarthritis.org/antisynthetase-syndrome-blog

https://pmc.ncbi.nlm.nih.gov/articles/PMC5006392/

https://www.myositis.org/about-myositis/complications/antisynthetase-syndrome/

https://myositis.org.au/antisynthetase-syndrome-patient-s/

https://lungfoundation.com.au/support-resources/resource-hub/antisynthetase-syndrome/

https://understandingmyositis.org/myositis/antisynthetase-syndrome/

FAQ

Can antisynthetase syndrome be cured?

There is currently no cure for antisynthetase syndrome. However, symptoms can be managed with a combination of medications and therapies, and some patients can achieve remission, especially if they have milder lung disease and continue their treatment.

What is the most dangerous aspect of antisynthetase syndrome?

The most serious complication is interstitial lung disease, which affects between 67% and 100% of patients. Severe and extensive lung disease is the factor most frequently associated with early death in people with antisynthetase syndrome.

Will I need to take medication for the rest of my life?

Many patients need to remain on medication for their entire lives to keep symptoms under control. Some medications may take two or three months to have their full effect. Blood work is taken periodically to assess changes and make adjustments to the treatment plan as needed.

What causes the immune system to attack the body in antisynthetase syndrome?

Experts don’t know exactly what causes antisynthetase syndrome. The condition involves the production of autoantibodies that attack enzymes called tRNA synthetases, which are important for protein building in the body, but why the immune system starts making these harmful antibodies remains unknown.

Can I still exercise with antisynthetase syndrome?

Yes, maintaining an active lifestyle is very important, but it may be hard to exercise without pain depending on your symptoms. Going to physical or occupational therapy can be very helpful in strengthening muscles and learning appropriate exercises. Pulmonary rehabilitation can help those with lung involvement maximize their breathing capacity.

🎯 Key takeaways

  • Antisynthetase syndrome affects fewer than 50,000 people in the U.S., making it rare enough that many doctors may never see a case in their entire career.
  • The estimated ten-year survival rate is about 76.8%, with lung disease severity being the most important factor affecting long-term outlook.
  • Lung involvement occurs in nearly all patients (67-100%), and for some people, breathing problems may be the very first sign that something is wrong.
  • Symptoms can vary wildly from person to person—some may have severe muscle weakness while others primarily struggle with lung disease or joint pain.
  • Mechanic’s hands (rough, cracked skin on palms and fingers) gets its name because it makes hands look like those of someone who works with their hands all day—but it’s actually caused by immune system inflammation.
  • Disease flares are more likely to happen when medications are reduced too quickly, which is why doctors typically taper treatments very slowly over many months.
  • Between 20-25% of people diagnosed with dermatomyositis or polymyositis actually have antisynthetase syndrome, highlighting how diagnosis can be complex.
  • In some cases, progressive lung disease can advance to the point where a lung transplant becomes the only remaining treatment option.